Abstract

BackgroundMost lymph node metastasis (LNM) models for early gastric cancer (EGC) include lymphovascular invasion (LVI) as a predictor. However, LVI must be confirmed by postoperative pathology. In this study, we aimed to develop a model for predicting the risk of LNM/LVI in EGC using preoperative factors.MethodsEGC patients who underwent radical gastrectomy at Fujian Medical University Union Hospital and Sun Yat-sen University Cancer Center (n = 1460) were selected as the training set. The risk factors of LNM/LVI were investigated. Data from the International study group on Minimally Invasive surgery for GASTRIc Cancer trial (n = 172) were selected as the validation set.ResultsIn the training set, the incidence of LNM/LVI was 21.6%. The 5-year cancer-specific survival rates of patients with and without LNM/LVI were 92.4 and 95.0%, respectively, with significant difference (P = 0.030). Multivariable logistic regression analysis showed that the four independent risk factors for LNM/LVI were female, tumor larger than 20 mm, submucosal invasion and undifferentiated tumor histological type (all P < 0.05); the area under the curve (AUC) was 0.694 (95% confidence interval [CI]: 0.659–0.730). Patients were divided into low-risk, intermediate-risk, high-risk and extremely high-risk groups by recursive partitioning analysis; the incidences of LNM/LVI were 5.4, 12.6, 24.2 and 37.8%, respectively (P < 0.001). The AUC of the validation set was 0.796 (95%CI, 0.662–0.851) and the predictive performance of the LNM/LVI risk in the validation set was consistent with that in the training set.ConclusionsThe risk of LNM/LVI in differentiated mucosal EGC is low, which indicated that endoscopic resection is a treatment option. The risk of LNM/LVI in undifferentiated mucosal EGC and submucosa EGC are high and gastrectomy with lymph node dissection is suggested.

Highlights

  • Most lymph node metastasis (LNM) models for early gastric cancer (EGC) include lymphovascular invasion (LVI) as a predictor

  • In the 315 cases with LNM/LVI, LNM−/LVI+ accounted for 44 cases (14.0%), LNM+/LVI- accounted for 226 cases (71.7%), and LNM+/LVI+ accounted for 45 cases (14.3%) (Fig. 1)

  • The results showed that the incidence of LNM/LVI was significantly lower in men < 60 years old than in women (18.5 vs. 27.6, P = 0.004)

Read more

Summary

Introduction

Most lymph node metastasis (LNM) models for early gastric cancer (EGC) include lymphovascular invasion (LVI) as a predictor. We aimed to develop a model for predicting the risk of LNM/LVI in EGC using preoperative factors. For patients with EGC who already have LNM, such treatment may risk postoperative tumor recurrence [4, 5]. Most studies on the LNM of EGC include lymphovascular invasion (LVI) as one of the predictors [6, 7]. Current predictive models for a simultaneous assessment of LNM/LVI risk in EGC have not been reported. This study explored the available preoperative factors for LNM/LVI in EGC and stratified the risk of LNM/LVI based on recursive partitioning analysis (RPA) using international multicenter data

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call